Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development Conference

作者：Sol Sherry, William Robert Bell, F Duckert, Anthony P. Fletcher, Victor Gurewich, David Michel Long, Victor J. Marder, Harold R. Roberts, Edwin W. Salzman, Arthur A. Sasahara, Marc Verstraete · 发表于：Annals of Internal Medicine · 年份：1980 · DOI：10.7326/0003-4819-93-1-141 · 被引用次数：199 · 研究领域：Venous Thromboembolism Diagnosis and Management

Symposium1 July 1980Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development ConferenceSOL SHERRY, WILLIAM R. BELL, F. H. DUCKERT, ANTHONY P. FLETCHER, VICTOR GUREWICH, DAVID M. LONG, VICTOR J. MARDER, HAROLD ROBERTS, EDWIN W. SALZMAN, ARTHUR SASAHARA, MARC VERSTRAETESOL SHERRY, WILLIAM R. BELL, F. H. DUCKERT, ANTHONY P. FLETCHER, VICTOR GUREWICH, DAVID M. LONG, VICTOR J. MARDER, HAROLD ROBERTS, EDWIN W. SALZMAN, ARTHUR SASAHARA, MARC VERSTRAETEAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-93-1-141 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptFor over three decades, the primary method of therapy used by almost all physicians for the management of acute deep-vein thrombosis and pulmonary embolism has been anticoagulation. This form of therapy has become so ingrained in medical practice that physicians, although still concerned over the bleeding risk associated with the use of anticoagulants, nevertheless seem secure in the belief that they are providing optimal, if not ideal, therapy for these disorders. With the advent of thrombolytic therapy (the thrombolytic agents considered at this conference were urokinase and streptokinase), this is no longer true for many cases. Anticoagulation for the management... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffili...